etranacogene dezaparvovec (aav5-padua hfix variant): two year data from a phase 2b trial
Published 3 years ago • 78 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
6:13
6 month data from the phase 3 etranacogene dezaparvovec hope-b gene therapy trial
-
5:18
hope-b: etranacogene dezaparvovec in adult hemophilia b
-
5:34
steven pipe: etranacogene dezaparvovec gene therapy for hemophilia b
-
8:50
updates from the hope-b trial: etranacogene dezaparvovec in adults with hemophilia b
-
3:49
hope-b trial: etranacogene dezaparvovec shows promise in hemophilia b
-
4:58
final analysis from the pivotal phase 3 hope-b trial of etranacogene dezaparvovec
-
20:34
gene therapy for treatment of hemophilia: aav vector gene therapy application to hemophilia
-
23:28
gene therapy for treatment of hemophilia: an introduction to aav vector gene transfer
-
15:27
gene therapy -- the time is now: nick leschly at tedxboston
-
18:21
gene therapy for the treatment of hemophilia b: andrew m. davidoff, md at tedxsonomacounty
-
37:50
quantitative measurements of hemophiliac joint tissues by point-of-care musculoskeletal ultrasound
-
3:58
follow-up of patients with hemophilia b treated with fidanacogene elaparvovec aav gene therapy
-
0:57
aav gene transfer for hemophilia
-
0:59
giroctocogene fitelparvovec phase 1/2 trial
-
0:44
current aav hemophilia b gene therapy trials
-
6:30
ehc gene therapy - a patients perspective
-
3:38
gene therapy: an end to hemophilia
-
15:04
uniqure
-
0:51
empowering patients with hemophilia to make choices about gene therapy
-
3:23
new approaches to hemophilia research
-
5:00
valoctocogene roxaparvovec aav gene transfer for severe hemophilia: results from phase 3 trial
-
4:39
a post hoc analysis of the gener8 1 phase 3 trial